Cargando…
Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713644/ https://www.ncbi.nlm.nih.gov/pubmed/33273671 http://dx.doi.org/10.1038/s41598-020-78512-x |
_version_ | 1783618597706268672 |
---|---|
author | Ahn, Soomin Lee, Jong- chan Shin, Dong Woo Kim, Jaihwan Hwang, Jin‑ Hyeok |
author_facet | Ahn, Soomin Lee, Jong- chan Shin, Dong Woo Kim, Jaihwan Hwang, Jin‑ Hyeok |
author_sort | Ahn, Soomin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7713644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-77136442020-12-08 Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer Ahn, Soomin Lee, Jong- chan Shin, Dong Woo Kim, Jaihwan Hwang, Jin‑ Hyeok Sci Rep Author Correction Nature Publishing Group UK 2020-12-03 /pmc/articles/PMC7713644/ /pubmed/33273671 http://dx.doi.org/10.1038/s41598-020-78512-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Ahn, Soomin Lee, Jong- chan Shin, Dong Woo Kim, Jaihwan Hwang, Jin‑ Hyeok Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
title | Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
title_full | Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
title_fullStr | Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
title_full_unstemmed | Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
title_short | Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
title_sort | author correction: high pd-l1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713644/ https://www.ncbi.nlm.nih.gov/pubmed/33273671 http://dx.doi.org/10.1038/s41598-020-78512-x |
work_keys_str_mv | AT ahnsoomin authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer AT leejongchan authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer AT shindongwoo authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer AT kimjaihwan authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer AT hwangjinhyeok authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer |